Purchases and Sales Made in Q1 2024 in Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO) during Q1 2024. The information is specifically focused on institutions that hold shares of Akero Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-163K- 33.33% |
$2.89M - $5.07M
|
325K
$16.7M
|
|
|
May 15, 2024
Q1 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-176K- 71.3% |
$3.12M - $5.47M
|
70.7K
$3.64M
|
|
|
May 14, 2024
Q1 2024
|
Long Focus Capital Management, LLC
San Juan, PR |
SELL
|
- |
-181K- 35.57% |
$3.22M - $5.66M
|
329K
$16.9M
|
|
|
May 15, 2024
Q1 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-238K- 96.53% |
$4.23M - $7.43M
|
8.58K
$442K
|
|
|
May 15, 2024
Q1 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-355K- 55.13% |
$6.31M - $11.1M
|
289K
$14.9M
|
|
|
May 14, 2024
Q1 2024
|
Alkeon Capital Management LLC
New York, NY |
SELL
|
- |
-437K- 11.61% |
$7.76M - $13.6M
|
3.33M
$171M
|
|
|
May 15, 2024
Q1 2024
|
Yiheng Capital Management, L.P.
San Francisco, CA |
SELL
|
- |
-489K- 25.45% |
$8.69M - $15.3M
|
1.43M
$73.8M
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-543K- 57.33% |
$9.64M - $16.9M
|
404K
$20.8M
|
|
|
Aug 16, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-653K- 61.8% |
$11.6M - $20.4M
|
404K
$20.8M
|
|
|
May 15, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-653K- 61.8% |
$11.6M - $20.4M
|
404K
$20.8M
|
|
|
May 15, 2024
Q1 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-1.33M- 25.87% |
$23.5M - $41.3M
|
3.8M
$195M
|